МУЛЬТИСИСТЕМНЫЙ ВОСПАЛИТЕЛЬНЫЙ СИНДРОМ У ВЗРОСЛЫХ: КАК ДОКАЗАТЬ И ЧЕМ ЛЕЧИТЬ?
Аннотация
Пандемия новой коронавирусной инфекции создала серьезные угрозы для физического здоровья населения и вызвала широкий спектр осложнений, развившихся как в острый период болезни, так и у переболевших. В статье рассмотрен мультисистемный воспалительный синдром, который был описан с началом пандемии у детей и подростков, а затем у взрослых. Представлены данные о распространенности, особенностях клинических проявлений, диагностики, в том числе дифференциальной, и лечения мультисистемного воспалительного синдрома у взрослых. Проведен анализ публикаций, посвященных сериям случаев, систематических обзоров случаев мультисистемного воспалительного синдрома у взрослых при помощи баз данных eLIBRARY, Scopus, PubMed и Google Scholar.
Литература
Кантемирова М.Г., Новикова Ю.Ю., Овсянников Д.Ю. и др. Детский мультисистемный воспалительный синдром, ассоциированный с новой коронавирусной инфекцией (COVID-19): актуальная информация и клиническое наблюдение. Педиатрическая фармакология. 2020;17(3):219–229.
Методические рекомендации «Особенности течения Long-COVID-инфекции. Терапевтические и реабилитационные мероприятия». Терапия. 2022;1(Приложение):1–147.
Министерство здравоохранения России. Временные методические рекомендации по профилактике, диагностике и лечению новой коронавирусной инфекции (COVID-19). Версия 18 от 26.10.2023. Доступен по: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/064/609/original/ВМР_short_V18.pdf (дата обращения: 25.07.2024).
Потапенко В.Г., Потихонова Н.А., Байков В.В. и др. Вторичный гемофагоцитарный синдром у взрослых в клинической практике гематолога: обзор литературы и собственные данные. Клиническая онкогематология. 2015;8(2):169–184.
Amato M.K., Hennessy C., Shah K. et al. Multisystem inflammatory syndrome in an adult. J Emerg Med. 2021;61(1):1–3. DOI: 10.1016/j.jemermed.2021.02.007.
Atchessi N., Edjoc R., Striha M. et al. Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review. Canada Communicable Disease Report. 2021;47(7-8):305–315. DOI: 10.14745/ccdr.v47i78a03.
Bastug A., Aslaner H., Aybar Bilir Y. et al. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent. Rheumatology International. 2021;41(5):993–1008. DOI: 10.1007/s00296-021-04843-1.
Belay E.D., Abrams J., Oster M.E. et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatrics. 2021;175(8):837–845.
Belhadjer Z., Méot M., Bajolle F. et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429–436. DOI: 10.1161/CIRCULATIONAHA.120.048360.
Carvalho V., Damasco P.H., Mello T.S. et al. Para-aortic lymphadenopathy associated with adult COVID-19 multisystem inflammatory syndrome. BMJ Case Rep. 2021;14(12):246884. DOI: 10.1136/bcr-2021-246884.
Costa A.E., Bernasconi N.S., Trendelenburg M. et al. Severe myopathy complicating multisystem inflammatory syndrome in adults (MIS-A) in a young man. BMJ Case Reports CP. 2022;15:250054. DOI: 10.1136/bcr-2022-250054.
DeBiasi R.L., Song X., Delaney M. et al. Severe coronavirus disease-2019 in children and young adults in the Washington, DC, Metropolitan Region. J. Pediatr. 2020;223:199–203. DOI: 10.1016/j.jpeds.2020.05.007.
DeCuir J., Baggs J., Melgar M. et al. Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare Database. Epidemiology and Infection. 2022;150:26. DOI: 10.1017/s0950268822000024.
Downing S., Chauhan V., Chaudry I.H. et al. Colchicine, Aspirin, and Montelukast — A Case of Successful Combined Pharmacotherapy for Adult Multisystem Inflammatory Syndrome in COVID-19. J Glob Infect Dis. 2020;12(4):221–224. DOI: 10.4103/jgid.jgid_296_20.
Farooqi K.M., Chan A., Weller R.J. et al. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021;148(2):e2021051155. DOI: 10.1542/peds.2021-051155.
Feldstein L.R., Tenforde M.W., Friedman K.G. et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA. 2021;325(11):1074–1087. DOI: 10.1001/jama.2021.2091.
Gurin M.I., Lin Y.J., Bernard S. et al. Cardiogenic shock complicating multisystem inflammatory syndrome following COVID-19 infection: a case report. BMC Cardiovasc Disord. 2021;21(1):522. DOI: 10.1186/s12872-021-02304-y.
Henderson L.A., Canna S.W., Friedman K.G. et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022;74(4):1–20. DOI: 10.1002/art.42062.
Hookham L., Fisher C., Manson J.J. et al. Understanding the diagnosis and management of multisystem inflammatory syndrome in adults (MIS-A) in the UK: results of a national Delphi process. Clinical Medicine (London, England). 2022;22(3):266–270. DOI: 10.7861/clinmed.2021-0700.
Hosseini P., Fallahi M.S., Erabi G. et al. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci. 2022;9:804109. DOI: 10.3389/fmolb.2022.804109.
Jones V.G., Mills M., Suarez D. et al. COVID-19 and Kawasaki disease: Novel virus and novel case. Hosp Pediatr. 2020;10(6):537–540. DOI: 10.1542/hpeds.2020-0123.
Kumar M.A., Krishnaswamy M., Arul J.N. Post COVID-19 sequelae: Venous thromboembolism complicated by lower GI bleed. BMJ Case Rep. 2021;14(1):241059. DOI: 10.1136/bcr-2020-241059.
Kunal S., Ish P., Sakthivel P. et al. The emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: A systematic review. Heart Lung. 2022;54:7–18. DOI: 10.1016/j.hrtlng.2022.03.007.
McCrindle B.W., Rowley A.H., Newburger J.W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):927–999. DOI: 10.1161/CIR.0000000000000703.
Mittal N., Abohelwa M., Brogan J. et al. A case report of multisystem inflammatory syndrome in adults (MIS-A) associated with heart failure. Eur Heart J Case Rep. 2021;5(10):381. DOI: 10.1093/ehjcr/ytab381.
Morris S.B., Schwartz N.G., Patel P. et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection — United Kingdom and United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450–1456. DOI: 10.15585/mmwr.mm6940e1.
Multisystem inflammatory syndrome in adults (MIS-A) case definition information for healthcare providers. Centers for Disease Control and Prevention. Доступен по: https://www.cdc.gov/mis/hcp/case-definition-reporting (дата обращения: 25.07.2024).
Nawfal O., Toufaili H., Dib G. et al. New-onset refractory status epilepticus as an early manifestation of multisystem inflammatory syndrome in adults after COVID-19. Epilepsia. 2022;63(5):51–56. DOI: 10.1111/epi.17231.
Parums D.V. Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19. Med Sci Monit. 2021;27:935005. DOI: 10.12659/MSM.935005.
Patel P., DeCuir J., Abrams J. et al. Clinical characteristics of multisystem inflammatory syndrome in adults: A systematic review. JAMA Netw. Open. 2021;4(9):2126456. DOI: 10.1001/jamanetworkopen.2021.26456.
Qamar M.A., Afzal S.S., Dhillon R.A. et al. A global systematic review and meta-analysis on the emerging evidence on risk factors, clinical characteristics, and prognosis of multisystem inflammatory syndrome in adults (MIS-A). Annals of Medicine and Surgery. 2023;85(9):4463–4475. DOI: 10.1097/ms9.0000000000000732.
Riphagen S., Gomez X., Gonzalez-Martinez C. et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608.
Schultz J.C., Hilliard A.A., Cooper L.T. Jr. et al. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009;84(11):1001–9. DOI: 10.1016/S0025-6196(11)60670-8.
Shen M., Milner A., Foppiano Palacios C. et al. Multisystem inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection with delayed-onset myocarditis: case report. Eur Heart J Case Rep. 2021;5:470. DOI: 10.1093/ehjcr/ytab470.
Stratton C.W., Tang Y.W., Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol. 2021;93:1320–1342. DOI: 10.1002/ jmv.26610.
Tahaghoghi-Hajghorbani S., Zafari P., Masoumi E. et al. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res. 2020;290:198197. DOI: 10.1016/j.virusres.2020.198197.
Townsend L., Fogarty H., Dyer A. et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb Haemost. 2021;19(4):1064–1070. DOI: 10.1111/jth.15267.
Vogel T.P., Top K.A., Karatzios C. et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3037–3049. DOI: 10.1016/j.vaccine.2021.01.054.
Vujaklija Brajković A., Zlopaša O., Gubarev Vrdoljak N. et al. Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19. Clinics and Research in Hepatology and Gastroenterology. 2021;45(3):101678. DOI: 10.1016/j.clinre.2021.101678.
Weatherhead J.E., Clark E., Vogel T.P. et al. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum. J. Clin Invest. 2020;130(12):6194–6197. DOI: 10.1172/JCI145301.
Weisberg S.P., Connors T.J., Zhu Y. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021;22(1):25–31. DOI: 10.1038/s41590-020-00826-9.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. May 15, 2020. Доступен по: https://www.who.int/ news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-childrenand-adolescents-with-covid-19 (дата обращения: 09.11.2023).
Yamada Y., Fujinami K., Eguchi T. et al. Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan. Emerging Infectious Diseases. 2021;27(6):1740–1742. DOI: 10.3201/eid2706.210728.
